Index - P/E 15.62 EPS (ttm) 5.83 Insider Own 3.03% Shs Outstand 99.95M Perf Week -10.55%
Market Cap 9.11B Forward P/E 12.65 EPS next Y 7.20 Insider Trans -2.11% Shs Float 96.97M Perf Month -11.16%
Income 611.00M PEG 2.41 EPS next Q 1.45 Inst Own 94.75% Short Float 4.39% Perf Quarter 13.31%
Sales 20.55B P/S 0.44 EPS this Y -10.50% Inst Trans 2.75% Short Ratio 3.66 Perf Half Y 61.23%
Book/sh 16.09 P/B 5.66 EPS next Y 15.29% ROA 2.20% Short Interest 4.26M Perf Year 37.29%
Cash/sh 12.28 P/C 7.42 EPS next 5Y 6.49% ROE 44.44% 52W Range 51.04 - 107.80 Perf YTD 20.52%
Dividend Est. - P/FCF 5.61 EPS past 5Y 40.40% ROI 3.49% 52W High -15.51% Beta 2.15
Dividend TTM - Quick Ratio 1.42 Sales past 5Y 2.48% Gross Margin 11.92% 52W Low 78.45% ATR (14) 2.99
Dividend Ex-Date Mar 13, 2000 Current Ratio 1.51 EPS Y/Y TTM 56.53% Oper. Margin 11.81% RSI (14) 28.09 Volatility 3.81% 2.55%
Employees 106500 Debt/Eq 10.08 Sales Y/Y TTM 7.17% Profit Margin 2.97% Recom 1.45 Target Price 113.11
Option/Short Yes / Yes LT Debt/Eq 9.88 EPS Q/Q 144.28% Payout 0.00% Rel Volume 2.08 Prev Close 96.00
Sales Surprise 2.03% EPS Surprise 67.31% Sales Q/Q 7.80% Earnings Apr 30 BMO Avg Volume 1.16M Price 91.08
SMA20 -10.56% SMA50 -6.04% SMA200 17.53% Trades
Volume 2,381,452 Change -5.12%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-27-24 Upgrade Wolfe Research
Peer Perform → Outperform
$122
Mar-06-24 Initiated Barclays
Overweight
$113
Apr-21-23 Initiated Cantor Fitzgerald
Overweight
$73
Apr-19-23 Initiated JP Morgan
Overweight
$72
Jun-17-22 Initiated Loop Capital
Buy
$80
Mar-29-22 Initiated Wells Fargo
Overweight
$100
Feb-10-22 Upgrade UBS
Neutral → Buy
$83 → $111
Feb-09-22 Upgrade Truist
Hold → Buy
$90
Feb-09-22 Upgrade SVB Leerink
Mkt Perform → Outperform
$88 → $100
Jan-20-22 Upgrade Raymond James
Outperform → Strong Buy
$105 → $120
Jan-10-22 Resumed Citigroup
Buy
$91 → $96
Sep-27-21 Initiated SVB Leerink
Mkt Perform
$80
Sep-24-21 Initiated UBS
Neutral
$83
Aug-12-21 Upgrade Barclays
Equal Weight → Overweight
$62 → $77
Jul-23-21 Resumed Citigroup
Buy
$88
Jul-09-21 Initiated Seaport Global Securities
Buy
$80
May-03-21 Resumed Goldman
Buy
$89
Jan-08-21 Upgrade Jefferies
Hold → Buy
$60
Jan-05-21 Upgrade BofA Securities
Neutral → Buy
$50
Dec-15-20 Upgrade Deutsche Bank
Hold → Buy
$28 → $69
Show Previous Ratings
Apr-17-24 11:58PM
Apr-05-24 06:15PM
Apr-03-24 12:45PM
09:30AM
Apr-02-24 12:58PM
06:45AM
Loading…
Apr-01-24 06:45AM
Mar-28-24 08:00AM
Mar-22-24 06:15PM
Mar-15-24 01:49AM
Mar-13-24 06:15PM
Mar-08-24 11:54PM
Mar-05-24 06:15PM
Mar-01-24 12:26PM
Feb-29-24 06:45AM
04:57AM
06:15PM
Loading…
Feb-28-24 06:15PM
Feb-21-24 09:00AM
Feb-17-24 12:06AM
Feb-16-24 05:00PM
07:03AM
12:01AM
Feb-09-24 10:24AM
04:00AM
04:00AM
02:15AM
(Thomson Reuters StreetEvents)
Feb-08-24 07:24PM
12:35PM
12:30PM
07:51AM
07:47AM
07:03AM
Loading…
07:03AM
(Associated Press Finance)
06:57AM
06:30AM
Feb-06-24 10:34AM
Feb-05-24 09:16AM
Feb-02-24 09:12AM
Feb-01-24 08:03PM
(Morningstar Research) +7.70%
10:00AM
07:00AM
07:00AM
06:45AM
05:44AM
Jan-30-24 01:32PM
01:14PM
(The Wall Street Journal)
11:35AM
(The Wall Street Journal)
Jan-29-24 06:15PM
Jan-26-24 12:10PM
Jan-25-24 02:52AM
Jan-22-24 06:15PM
Jan-18-24 11:39AM
(The Wall Street Journal)
Jan-09-24 06:15PM
09:00AM
Dec-26-23 12:20PM
Dec-25-23 04:41AM
Dec-21-23 05:08AM
Dec-19-23 06:15PM
04:02AM
Dec-15-23 06:34PM
Dec-13-23 04:05PM
Nov-30-23 08:34AM
Nov-29-23 11:30AM
Nov-24-23 11:03PM
Nov-20-23 11:06AM
08:42AM
05:20AM
Nov-19-23 07:09PM
Nov-17-23 12:16PM
07:26AM
07:00AM
06:57AM
06:45AM
05:22AM
Nov-13-23 02:56PM
Nov-06-23 12:25PM
Oct-31-23 03:26PM
11:57AM
08:41AM
08:25AM
(Thomson Reuters StreetEvents)
06:49AM
01:15AM
Oct-30-23 08:30PM
06:16PM
06:00PM
05:50PM
04:47PM
(Associated Press Finance)
04:05PM
Oct-26-23 09:00AM
Oct-25-23 06:05PM
Oct-23-23 06:15PM
10:00AM
Oct-19-23 12:17PM
09:00AM
Oct-16-23 06:15PM
Oct-12-23 12:10PM
Oct-11-23 11:41AM
Oct-10-23 11:28AM
10:00AM
(The Wall Street Journal)
Oct-09-23 12:04PM
09:00AM
Oct-06-23 12:20PM
Tenet Healthcare Corp. engages in the provision of healthcare services. It operates through the Hospital Operations and Other, and Ambulatory Care segments. The Hospital Operations and Other segment is composed of acute care hospitals, ancillary outpatient facilities, urgent care centers, micro hospitals and physician practices. The Ambulatory Care segment includes the operations of the USPI joint venture and the company's nine Aspen facilities in the United Kingdom. The company was founded in 1969 and is headquartered in Dallas, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MARK RICHARD J Director Mar 12 '24 Sale 98.98 14,000 1,385,720 33,303 Mar 14 08:00 PM Arbour Paola M EVP, Chief Information Officer Mar 06 '24 Sale 96.96 18,168 1,761,569 29,803 Mar 08 08:00 PM Arnst Thomas W EVP, Chief Admin. Officer & GC Mar 01 '24 Sale 94.84 17,000 1,612,234 8,148 Mar 05 08:00 PM Lynch Christopher S. Director Feb 15 '24 Sale 89.60 7,978 714,829 25,620 Feb 16 08:15 PM FISHER RICHARD W Director Feb 14 '24 Sale 88.21 2,100 185,241 20,127 Feb 15 08:00 PM FISHER RICHARD W Director Nov 22 '23 Sale 68.22 1,000 68,220 22,227 Nov 24 04:17 PM FISHER RICHARD W Director Nov 21 '23 Sale 66.33 5,000 331,650 23,227 Nov 24 04:17 PM Arbour Paola M EVP, Chief Information Officer Jun 02 '23 Option Exercise 31.46 38,556 1,212,952 54,357 Jun 06 04:46 PM Arbour Paola M EVP, Chief Information Officer Jun 02 '23 Sale 75.22 38,556 2,900,338 33,006 Jun 06 04:46 PM Arnst Thomas W EVP, Chief Admin. Officer & GC May 19 '23 Sale 73.12 21,178 1,548,602 0 May 23 05:01 PM
Index S&P 500 P/E 31.11 EPS (ttm) 7.30 Insider Own 1.14% Shs Outstand 181.50M Perf Week -4.56%
Market Cap 41.35B Forward P/E 18.11 EPS next Y 12.54 Insider Trans -3.80% Shs Float 179.95M Perf Month -10.62%
Income 1.36B PEG 2.71 EPS next Q 2.48 Inst Own 91.22% Short Float 1.61% Perf Quarter 6.56%
Sales 14.96B P/S 2.76 EPS this Y 8.93% Inst Trans 0.41% Short Ratio 3.01 Perf Half Y 14.16%
Book/sh 33.67 P/B 6.75 EPS next Y 12.88% ROA 5.22% Short Interest 2.89M Perf Year 12.06%
Cash/sh 8.22 P/C 27.64 EPS next 5Y 11.48% ROE 22.87% 52W Range 167.42 - 261.73 Perf YTD -1.82%
Dividend Est. - P/FCF 27.56 EPS past 5Y 42.42% ROI 6.96% 52W High -13.20% Beta 1.53
Dividend TTM - Quick Ratio 0.86 Sales past 5Y 7.76% Gross Margin 27.35% 52W Low 35.69% ATR (14) 5.48
Dividend Ex-Date - Current Ratio 0.86 EPS Y/Y TTM 27.39% Oper. Margin 13.63% RSI (14) 29.75 Volatility 2.39% 2.01%
Employees 87000 Debt/Eq 2.33 Sales Y/Y TTM 3.75% Profit Margin 9.08% Recom 1.62 Target Price 274.12
Option/Short Yes / Yes LT Debt/Eq 2.19 EPS Q/Q 111.43% Payout 0.00% Rel Volume 0.65 Prev Close 227.25
Sales Surprise 1.91% EPS Surprise 0.66% Sales Q/Q 3.20% Earnings May 02 BMO Avg Volume 961.41K Price 227.17
SMA20 -6.61% SMA50 -6.58% SMA200 3.36% Trades
Volume 631,234 Change -0.04%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-24 Initiated Leerink Partners
Outperform
$290
Feb-15-24 Downgrade Guggenheim
Buy → Neutral
Feb-13-24 Initiated BTIG Research
Buy
$285
Nov-02-23 Downgrade Robert W. Baird
Outperform → Neutral
$248 → $202
Sep-06-23 Initiated HSBC Securities
Buy
$260
Mar-17-23 Initiated Truist
Buy
$265
Dec-06-22 Initiated Cowen
Outperform
$251
Nov-17-22 Downgrade Citigroup
Buy → Neutral
$275 → $245
Aug-25-22 Initiated Credit Suisse
Outperform
$300
Jul-15-22 Initiated SVB Leerink
Outperform
$256
May-24-22 Initiated Guggenheim
Buy
$244
Apr-29-22 Upgrade Piper Sandler
Neutral → Overweight
$231 → $255
Apr-25-22 Downgrade Wells Fargo
Overweight → Equal Weight
$235
Aug-05-21 Resumed Credit Suisse
Outperform
$272
Apr-16-21 Upgrade Stephens
Equal-Weight → Overweight
$180 → $250
Mar-08-21 Upgrade KeyBanc Capital Markets
Sector Weight → Overweight
$218
Mar-03-21 Initiated Barclays
Overweight
$220
Jul-07-20 Initiated Stephens
Equal-Weight
$150
Mar-02-20 Initiated Deutsche Bank
Buy
$190
Jan-08-20 Initiated Wells Fargo
Overweight
$180
Show Previous Ratings
Apr-18-24 05:00PM
Apr-17-24 12:00PM
Apr-15-24 04:15PM
Apr-08-24 04:01PM
07:41AM
09:40AM
Loading…
Apr-04-24 09:40AM
09:08AM
Apr-02-24 11:39AM
Mar-20-24 07:44PM
Mar-15-24 01:38PM
11:30AM
Mar-13-24 12:07PM
Mar-06-24 04:15PM
Feb-27-24 08:00AM
Feb-26-24 08:00AM
09:00AM
Loading…
Feb-23-24 09:00AM
Feb-21-24 04:15PM
Feb-16-24 12:02AM
Feb-15-24 05:34PM
10:39AM
01:30AM
(Thomson Reuters StreetEvents)
Feb-14-24 06:29PM
(Morningstar Research) +13.10%
01:00PM
09:30AM
08:10AM
07:36AM
07:33AM
07:16AM
(Associated Press Finance)
07:00AM
Feb-09-24 09:26AM
09:15AM
Loading…
09:15AM
Feb-06-24 09:00AM
Jan-24-24 04:15PM
Jan-18-24 12:49PM
Jan-17-24 06:00AM
Jan-10-24 06:29PM
06:16PM
Jan-03-24 10:31AM
Jan-02-24 08:15AM
Dec-29-23 09:31PM
09:18PM
Dec-28-23 06:30PM
Dec-07-23 11:53AM
Dec-01-23 11:31AM
Nov-29-23 08:30AM
Nov-21-23 04:15PM
Nov-20-23 12:34PM
Nov-17-23 09:23AM
Nov-15-23 09:11AM
Nov-14-23 09:07AM
Nov-06-23 08:00AM
Nov-04-23 01:18PM
Nov-02-23 03:52PM
11:25AM
09:30AM
01:15AM
Nov-01-23 11:43PM
(Thomson Reuters StreetEvents)
11:36AM
09:36AM
08:34AM
08:25AM
08:16AM
08:04AM
07:30AM
(Associated Press Finance)
07:00AM
Oct-30-23 04:21PM
10:00AM
Oct-26-23 12:10PM
10:45AM
Oct-25-23 10:02AM
Oct-23-23 08:00AM
Oct-20-23 07:39AM
04:23AM
Oct-19-23 06:54AM
Oct-17-23 09:07AM
Oct-11-23 07:30AM
Oct-09-23 04:15PM
07:19AM
Oct-05-23 08:13AM
08:00AM
Oct-03-23 08:00AM
Sep-29-23 03:57PM
03:15PM
Sep-25-23 08:01PM
Sep-14-23 12:44PM
Sep-12-23 08:30AM
Sep-08-23 02:13PM
(Investor's Business Daily)
11:36AM
11:31AM
Sep-05-23 08:30AM
Sep-01-23 08:30AM
Aug-31-23 11:31AM
Aug-30-23 08:54AM
Aug-25-23 02:15PM
Aug-18-23 07:39AM
Aug-16-23 08:42PM
Aug-14-23 04:33PM
Aug-12-23 10:00AM
Aug-11-23 12:05PM
Aug-06-23 08:00AM
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions, and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
BOUSBIB ARI See Remarks Mar 01 '24 Option Exercise 65.16 42,847 2,791,911 828,430 Mar 04 05:28 PM BOUSBIB ARI See Remarks Mar 01 '24 Sale 250.53 31,678 7,936,193 796,752 Mar 04 05:28 PM STAUB W RICHARD See Remarks Feb 29 '24 Sale 247.80 14,100 3,494,034 15,945 Mar 04 05:27 PM Knightly Kevin C See Remarks Feb 28 '24 Option Exercise 87.40 13,206 1,154,211 13,858 Mar 01 05:07 PM Knightly Kevin C See Remarks Feb 28 '24 Sale 250.17 8,607 2,153,176 5,251 Mar 01 05:07 PM Knightly Kevin C See Remarks Feb 16 '24 Option Exercise 78.21 12,149 950,173 18,061 Feb 21 05:07 PM Knightly Kevin C See Remarks Feb 16 '24 Sale 241.10 13,468 3,247,165 652 Feb 21 05:07 PM Sherbet Eric See Remarks Feb 16 '24 Sale 241.50 1,000 241,500 20,836 Feb 21 05:08 PM Knightly Kevin C See Remarks Dec 01 '23 Option Exercise 62.26 18,491 1,151,185 20,464 Dec 05 05:01 PM Knightly Kevin C See Remarks Dec 01 '23 Sale 214.03 13,117 2,807,472 7,347 Dec 05 05:01 PM Panagos Constantinos See Remarks Sep 19 '23 Option Exercise 149.45 26,186 3,913,563 40,436 Sep 21 05:01 PM Panagos Constantinos See Remarks Sep 19 '23 Sale 208.67 27,317 5,700,340 14,250 Sep 21 05:01 PM Knightly Kevin C See Remarks Jun 05 '23 Sale 201.89 5,820 1,175,000 0 Jun 07 05:31 PM Knightly Kevin C See Remarks May 26 '23 Sale 198.66 1 199 0 May 31 09:29 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
